Atovaquone — Active Pharmaceutical Ingredient

Atovaquone is an active pharmaceutical ingredient found in 5 FDA-approved drug products. Forms: TABLET, SUSPENSION. Routes: ORAL.

This content is for informational purposes only. Always consult a healthcare professional.

Atovaquone (5 brand names, 2 dosage forms, 1 route)

Available dosage forms: TABLET, SUSPENSION.

Routes of administration: ORAL.

Brand Names

  • ATOVAQUONE
  • ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
  • MALARONE
  • MALARONE PEDIATRIC
  • MEPRON

Contraindications

MEPRON oral suspension is contraindicated in patients who develop or have a history of hypersensitivity reactions to atovaquone or any of the components of MEPRON [see Warnings and Precautions (5.3), Adverse Reactions (6.2)].

Adverse Reactions

The following adverse reactions are discussed in another section of the labeling: •Hepatotoxicity [see Warnings and Precautions (5.2)]. •Severe Cutaneous Adverse Reactions [see Warnings and Precautions (5.3)].

Mechanism of Action

Atovaquone is a quinone antimicrobial drug [see Microbiology (12.4)].

Overdosage

Overdoses up to 31,500 mg of atovaquone have been reported. In one such patient who also took an unspecified dose of dapsone, methemoglobinemia occurred. Rash has also been reported after overdose. There is no known antidote for atovaquone, and it is currently unknown if atovaquone is dialyzable.

⚠ Caution
Medical Disclaimer: This information is for educational purposes only. Always consult a healthcare professional before taking any medication.